Is waiving vaccine patents the panacea?

Spoor & Fisher Partner, Prof. John McKnight joins Michael Avery and a panel of experts on Business Day TV to talk about the US backing India and SA’s bid to temporarily lift patent protection for Covid-19 vaccines.

Watch the interview below.

Date published: 13 May
Author: Spoor & Fisher

Tags: covid vaccine intellectualproperty patent trips waiver wto